Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell S Berman

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|May 4, 2012
Histology-specific microRNA alterations in melanomaLaura Poliseno, Adele Haimovic, Miguel F Segura, et al.
Oncology|June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of CareChloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
Journal of Surgical Oncology|January 26, 2021
Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitalsGerardo A Vitiello, Annie Wang, Rachel M Lee, et al.
Langenbeck'S Archives of Surgery|July 19, 2024
What is the optimal surgical approach for ductal adenocarcinoma of the pancreatic neck? - a retrospective cohort studyIngmar F Rompen, Joseph R Habib, Elisabetta Sereni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patientsBruce Ng, Jan Zakrzewski, Melanie Warycha, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2012
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph nodeMichelle W Ma, Ratna C Medicherla, Meng Qian, et al.
Journal of Translational Medicine|August 4, 2012
Serum microRNAs as biomarkers for recurrence in melanomaErica B Friedman, Shulian Shang, Eleazar Vega-Saenz de Miera, et al.
Journal of Translational Medicine|November 26, 2008
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsJessie Z Yu, Melanie A Warycha, Paul J Christos, et al.
Annals of Surgery|October 23, 2023
Progression of Site-specific Recurrence of Pancreatic Cancer and Implications for TreatmentIngmar F Rompen, Jonah Levine, Joseph R Habib, et al.
Annals of Surgical Oncology|February 26, 2026
Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 TrialEyal Mor, Sameer Apte, Mathias Bressel, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|May 4, 2012
Histology-specific microRNA alterations in melanomaLaura Poliseno, Adele Haimovic, Miguel F Segura, et al.
Oncology|June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of CareChloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
Journal of Surgical Oncology|January 26, 2021
Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitalsGerardo A Vitiello, Annie Wang, Rachel M Lee, et al.
Langenbeck'S Archives of Surgery|July 19, 2024
What is the optimal surgical approach for ductal adenocarcinoma of the pancreatic neck? - a retrospective cohort studyIngmar F Rompen, Joseph R Habib, Elisabetta Sereni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patientsBruce Ng, Jan Zakrzewski, Melanie Warycha, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2012
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph nodeMichelle W Ma, Ratna C Medicherla, Meng Qian, et al.
Journal of Translational Medicine|August 4, 2012
Serum microRNAs as biomarkers for recurrence in melanomaErica B Friedman, Shulian Shang, Eleazar Vega-Saenz de Miera, et al.
Journal of Translational Medicine|November 26, 2008
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsJessie Z Yu, Melanie A Warycha, Paul J Christos, et al.
Annals of Surgery|October 23, 2023
Progression of Site-specific Recurrence of Pancreatic Cancer and Implications for TreatmentIngmar F Rompen, Jonah Levine, Joseph R Habib, et al.
Annals of Surgical Oncology|February 26, 2026
Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 TrialEyal Mor, Sameer Apte, Mathias Bressel, et al.
Pageof 10